Table 2

Prevalence rates of Barrett's oesophagus (BO) in Asia

CountryReferenceStudy populationPrevalence rate
AustraliaKendall and Whiteman135Unselected patients undergoing endoscopy
(N=2593)
1.89%
ChinaXiong et al136Unselected patients undergoing endoscopy
(N=2022)
1%
IndiaDhawan et al137Unselected patients undergoing endoscopy
(N=271)
6%
Mathew et al138Patients with reflux disease (N=278)9% had CLO with IM; 16.54% had CLO
JapanOkita et al139Unselected patients undergoing endoscopy
(N=5338)
Overall: 37.6%
SSBO (mean length 0.77±0.43cm): 37.4%
LSBO: 0.2%
Watari et al140Unselected patients undergoing endoscopy
(N=1581)
SSBO: 5.4%
LSBO: 0.2%
(Ultrashort: 30.8%)
KoreaPark et al141Multicentre Korean study of patients undergoing endoscopy
(N=25 536)
0.84%
MalaysiaRosaida and Goh142Unselected patients undergoing endoscopy
(N=1000)
2%
SingaporeAng et al143Patients with reflux disease (N=533)1.7%
TaiwanTseng et al145Health screening patients who underwent endoscopy (N=19 812)0.061%
  • CLO, columnar lined oesophagus; IM, intestinal metaplasia; LSBO, long segment BO; SSBO, short segment BO.